a month ago
LEGN
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 39%
#1775 out of 4565 analysts
Average Return
+0.33%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-02 - 2024-01-24 | Strong Buy |
Arcellx IncACLX | +46.13% | $35.16 | $51.38 | 2023-10-16 - 2024-04-25 | Strong Buy |
Neurocrine Biosciences IncNBIX | +43.46% | $96.03 | $137.76 | 2023-07-12 - 2024-04-25 | Strong Buy |
Neurocrine Biosciences IncNBIX | +37.07% | $100.38 | $137.59 | 2023-04-03 - 2024-04-03 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +34.11% | $9.88 | $13.25 | 2023-11-26 - 2024-04-25 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
4 months ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biohaven LtdBHVN | 2 | Strong Buy | $60.00 | +55.68% | Maintains | 3 days ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $81.00 | +82.35% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Hold | $131.00 | +21.94% | Maintains | 2 months ago |
Alkermes PLCALKS | 2 | Strong Sell | $25.00 | +2.29% | Downgrades | 2 months ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $111.00 | +55.20% | Initiates Coverage On | 3 months ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $21.00 | +17.85% | Initiates Coverage On | 3 months ago |
Cytokinetics IncCYTK | 4 | Hold | $92.00 | +41.98% | Downgrades | 3 months ago |
Intra Cellular Therapies IncITCI | 3 | Strong Buy | $82.00 | +13.68% | Maintains | 4 months ago |
Teva Pharmaceutical Industries LtdTEVA | 4 | Strong Buy | $13.00 | -1.89% | Upgrades | 5 months ago |
Arcellx IncACLX | 1 | Strong Buy | $52.00 | +1.21% | Initiates Coverage On | 6 months ago |
Acadia Pharmaceuticals IncACAD | 1 | Strong Buy | $33.00 | +102.33% | Initiates Coverage On | 6 months ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | -86.76% | Maintains | 9 months ago |
Neurocrine Biosciences IncNBIX | 3 | Strong Buy | $115.00 | -16.52% | Maintains | 9 months ago |
United Therapeutics CorpUTHR | 2 | Strong Buy | $310.00 | N/A | Maintains | a year ago |
Coherus Biosciences IncCHRS | 2 | Strong Buy | $11.00 | N/A | Upgrades | a year ago |
Royalty Pharma PLCRPRX | 2 | Strong Buy | $48.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | a year ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | a year ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.